multiple sclerosis. Demyelinating diseases of the central nervous system
Conditions
Interventions
Intervention 1: In the experimental groups were performed foot reflexology and relaxation intervention (Jacobson and Benson) within 4 weeks, twice a week for 40 minutes. Intervention 2: The control gr
Treatment - Other
Treatment - Drugs
In the experimental groups were performed foot reflexology and relaxation intervention (Jacobson and Benson) within 4 weeks, twice a week for 40 minutes
The control group was received only care and routine medical treatment as directed by a doctor.
Sponsors
Research Deputy Isfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : Women aged 18-50 years suffering from MS (relapsing-remitting, primary progressive and secondary progressive); MS final diagnosis by neurologists based on McDonald criteria with the elapse of at least 6 months from relevant diagnosis; tendency to participate in the research; no previous participation at treatment sessions of complementary medicine methods such as reflexology, relaxation, massage for the last 6 months; to feel chronic pain in at least one body organs, previous use of pain medication and Numerical Rating Scale (NRS); having the fatigue severity score of equal to and over 4 based on fatigue severity scale( FSS); have high scores of depression (more than 13), anxiety (more than 9) and stress (more than 18) based on DASS-21 scale; acquisition of scores 0-5.5 based on the Expanded Disability Status Scale( EDSS); not being in the menstruation period, nonexistence of deformity, callus or corn in the feet, feet lesion or cleft, active thrombosis or phlebitis, Varicose veins, record of latest ankle trauma, sprain, fracture, feet palm inflammation or infection; no affliction with diseases other than MS such as febrile acute or bodily chronic (flu, cardiac disabling, glands, respiratory, hepatic, skeletomuscular, renal), mental or psychic disorders such as severe depression, speech or hearing disorder; no addiction to narcotics and psychotropic; not being a member to the treatment crew (physician, nurse); to feel chronic pain in at least one body organs; previous use of pain medication and Numerical Rating Scale (NRS) pain score more 4 for at least 6 months; no pregnancy or no willingness to be pregnant and after taking of informed written consent. Exclusion criteria: No wanting to continue cooperation in research, use another CAM either current; absence of more than two session's acute relapse of the disease one month preceding ordering the study period or within study .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physical symptoms (pain,fatigue). Timepoint: Before, immediately and two months after interventions. Method of measurement: Questionnaire.;Mmental symptoms (stress ,anexity , depression). Timepoint: Before, immediately and two months after interventions. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFateme Nazari
Isfahan University of Medical Sciences
Outcome results
None listed